Quantcast

Latest Tykerb Stories

2010-03-03 13:18:10

A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation

2010-01-29 18:46:00

PHILADELPHIA, Jan. 29 /PRNewswire/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S.

2010-01-29 16:58:00

Provides oral regime for hormone positive and HER2-positive advanced breast cancer SILVER SPRING, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S.

2009-12-11 12:30:00

LONDON and PHILADELPHIA, Dec. 11 /PRNewswire/ -- In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab).

d4892899a41d2ccabf5f89ad79f3e281
2009-04-02 09:20:00

GlaxoSmithKline PLC has petitioned the United States and Europe for permission in to market an already accessible breast-cancer drug as a first-line treatment option.

2009-04-01 08:00:00

LONDON and PHILADELPHIA, April 1, /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the submission of two simultaneous regulatory applications to expand the use of TYVERB(R)/TYKERB(R) (lapatinib).

2006-06-03 14:18:49

By Lisa Richwine ATLANTA (Reuters) - An experimental drug added to chemotherapy slowed aggressive, late-stage breast cancers that resumed growing despite standard treatment with the drug Herceptin, U.S. researchers said on Saturday.


Word of the Day
dittany
  • An aromatic woolly plant (Origanum dictamnus) native to Crete, formerly believed to have magical powers.
The word 'dittany' may come from the name of Mount Diktē in Crete, where it was supposed to grow.
Related